These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 16619538)

  • 1. PCNA-LII, Ki-67 immunostaining, p53 activity and histopathological variables in predicting the clinical outcome in patients with parathyroid carcinoma.
    Lumachi F; Ermani M; Marino F; Iacobone M; Baldessin M; Cappuzzo G; Zanella S; Favia G
    Anticancer Res; 2006; 26(2A):1305-8. PubMed ID: 16619538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
    Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH
    Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between proliferating cell nuclear antigen and p53 protein expression and 5-year survival rate in nasopharyngeal carcinoma.
    Wang LF; Chai CY; Kuo WR; Tai CF; Lee KW; Ho KY
    Am J Otolaryngol; 2006; 27(2):101-5. PubMed ID: 16500472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological characteristics of adrenocortical carcinoma: a study of p53, IGF, EGF-r, Ki-67 and PCNA in 17 adrenocortical carcinomas.
    Edgren M; Eriksson B; Wilander E; Westlin JE; Nilsson S; Oberg K
    Anticancer Res; 1997; 17(2B):1303-9. PubMed ID: 9137490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated p21 expression is associated with poor prognosis of rectal stromal tumors after resection.
    Hu TH; Tai MH; Chuah SK; Chen HH; Lin JW; Huang HY; Chou YP; Yi LN; Kuo CM; Changchien CS
    J Surg Oncol; 2008 Aug; 98(2):117-23. PubMed ID: 18521824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.
    Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C
    Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical localization and correlation of p53 and PCNA expression in breast carcinoma.
    Goel MM; Goel R; Mehrotra A; Nath P; Agarwal PK; Singh K; Mehrotra R
    Indian J Exp Biol; 2000 Mar; 38(3):225-30. PubMed ID: 10927863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
    Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M
    Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
    Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
    Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
    Saeger W; Lüdecke B; Lüdecke DK
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of proliferating cell nuclear antigen (PCNA) and p53 protein expression in patients with advanced nasopharyngeal carcinoma.
    Wang LF; Chai CY; Kuo WR; Tai CF; Lee KW; Ho KY
    Acta Otolaryngol; 2006 Jul; 126(7):769-74. PubMed ID: 16803719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic relevance of proliferation marker Ki-67 (MIB 1), PCNA and p53 in combined surgically and radiologically treated cancers of the oropharynx and mouth cavity].
    Sittel C; Ruiz S; Kvasnicka HM; Volling P; Jungehülsing M; Eckel HE
    Laryngorhinootologie; 2000 Feb; 79(2):86-92. PubMed ID: 10738715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferating-cell nuclear antigen (PCNA) as an independent prognostic marker in patients after prostatectomy: a comparison of PCNA and Ki-67.
    Taftachi R; Ayhan A; Ekici S; Ergen A; Ozen H
    BJU Int; 2005 Mar; 95(4):650-4. PubMed ID: 15705097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lack of correlation between proliferation (Ki-67, PCNA, LI, Tpot), p53 expression and radiosensitivity for head and neck cancers.
    Björk-Eriksson T; West CM; Cvetskovska E; Svensson M; Karlsson E; Magnusson B; Slevin NJ; Edström S; Mercke C
    Br J Cancer; 1999 Jul; 80(9):1400-4. PubMed ID: 10424742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p53 protein in gastric cancer: an immunohistochemical study with correlation to proliferative activity.
    Ioachim E; Goussia A; Stefanou D; Agnantis NJ
    Anticancer Res; 1997; 17(1A):513-7. PubMed ID: 9066704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer.
    Yoshimatsu T; Uramoto H; Oyama T; Yashima Y; Gu C; Morita M; Sugio K; Kohno K; Yasumoto K
    Anticancer Res; 2005; 25(5):3437-43. PubMed ID: 16101161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb B-2 proteins on Reed-Sternberg cells: prognostic significance in Hodgkin's disease.
    Smolewski P; Niewiadomska H; Błonski JZ; Robak T; Krykowski E
    Neoplasma; 1998; 45(3):140-7. PubMed ID: 9717525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PCNA, Ki-67 and hTERT in residual benign meningiomas.
    Maes L; Kalala JP; Cornelissen M; De Ridder L
    In Vivo; 2006; 20(2):271-5. PubMed ID: 16634530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing.
    Lee JJ; Kuo MY; Cheng SJ; Chiang CP; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Apr; 99(4):471-8. PubMed ID: 15772596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.